{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T16:00:49Z","timestamp":1791907249348,"version":"4.3.4"},"reference-count":66,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,7,17]],"date-time":"2023-07-17T00:00:00Z","timestamp":1689552000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,7,17]],"date-time":"2023-07-17T00:00:00Z","timestamp":1689552000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Microbiol"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      This study was aimed to evaluate the prevalence and molecular characteristics of ciprofloxacin resistance among 346\n                      <jats:italic>Escherichia coli<\/jats:italic>\n                      isolates collected from clinical specimens (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u200982), healthy children (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u2009176), municipal wastewater (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u200934), hospital wastewater (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u200933), poultry slaughterhouse wastewater (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u200912) and livestock (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u20099) slaughterhouse wastewater in Iran.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      Ciprofloxacin minimum inhibitory concentration (MIC) was determined by agar dilution assay. Phylogroups and plasmid-mediated quinolone resistance (PMQR) genes were identified using PCR. Mutations in\n                      <jats:italic>gyrA<\/jats:italic>\n                      ,\n                      <jats:italic>gyrB<\/jats:italic>\n                      ,\n                      <jats:italic>parC,<\/jats:italic>\n                      and\n                      <jats:italic>parE<\/jats:italic>\n                      genes and amino acid alterations were screened through sequencing assay. The effect of efflux pump inhibitor (PA\u03b2N) on ciprofloxacin MICs in ciprofloxacin-resistant isolates was investigated using the microdilution method.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      In total, 28.03% of\n                      <jats:italic>E. coli<\/jats:italic>\n                      isolates were phenotypically resistant to ciprofloxacin. Based on sources of isolation, 64.63%, 51.51%, 33.33%, 14.70%, 10.22% and 8.33% of isolates from clinical specimens, hospital wastewater, livestock wastewater, municipal wastewater, healthy children and poultry wastewater were ciprofloxacin-resistant, respectively. Eighty-one point eighty-one percent (Ser-83\n                      <jats:bold>\u2009\u2192\u2009<\/jats:bold>\n                      Leu\u2009+\u2009Asp-87\u2009\u2192\u2009Asn; 78.78% and Ser-83\u2009\u2192\u2009Leu only; 3.03%\n                      <jats:bold>(<\/jats:bold>\n                      of ciprofloxacin-resistant\n                      <jats:italic>E. coli<\/jats:italic>\n                      isolates showed missense mutation in GyrA subunit of DNA gyrase, while no amino-acid substitution was noted in the GyrB subunit. DNA sequence analyses of the ParC and ParE subunits of topoisomerase IV exhibited amino-acid changes in 30.30% (Ser-80\u2009\u2192\u2009Ile\u2009+\u2009Glu-84\u2009\u2192\u2009Val; 18.18%, Ser-80\u2009\u2192\u2009Ile only; 9.10% and Glu-84\u2009\u2192\u2009Val only; 3.03%0 (and 15.38% (Ser-458\u2009\u2192\u2009Ala) of ciprofloxacin-resistant\n                      <jats:italic>E. coli<\/jats:italic>\n                      isolates, respectively. The PMQR genes,\n                      <jats:italic>aac(6')-Ib-cr<\/jats:italic>\n                      ,\n                      <jats:italic>qnrS<\/jats:italic>\n                      ,\n                      <jats:italic>qnrB<\/jats:italic>\n                      ,\n                      <jats:italic>oqxA<\/jats:italic>\n                      ,\n                      <jats:italic>oqxB,<\/jats:italic>\n                      and\n                      <jats:italic>qepA<\/jats:italic>\n                      were detected in 43.29%, 74.22%, 9.27%, 14.43%, 30.92% and 1.03% of ciprofloxacin-resistant isolates, respectively. No isolate was found to be positive for\n                      <jats:italic>qnrA<\/jats:italic>\n                      and\n                      <jats:italic>qnrD<\/jats:italic>\n                      genes. In isolates harboring the OqxA\/B efflux pump, the MIC of ciprofloxacin was reduced twofold in the presence of PA\u03b2N, as an efflux pump inhibitor. The phylogroups B\n                      <jats:sub>2<\/jats:sub>\n                      (48.45%) and A (20.65%) were the most predominant groups identified in ciprofloxacin-resistant isolates.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>\n                      This study proved the high incidence of ciprofloxacin-resistant\n                      <jats:italic>E. coli<\/jats:italic>\n                      isolates in both clinical and non-clinical settings in Iran. Chromosomal gene mutations and PMQR genes were identified in ciprofloxacin resistance among\n                      <jats:italic>E. coli<\/jats:italic>\n                      population.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12866-023-02940-8","type":"journal-article","created":{"date-parts":[[2023,7,17]],"date-time":"2023-07-17T05:02:00Z","timestamp":1689570120000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":29,"title":["Prevalence and mechanisms of ciprofloxacin resistance in Escherichia coli isolated from hospitalized patients, healthy carriers, and wastewaters in Iran"],"prefix":"10.1186","volume":"23","author":[{"given":"Zohreh","family":"Neyestani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farzad","family":"Khademi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roghayeh","family":"Teimourpour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mojtaba","family":"Amani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohsen","family":"Arzanlou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,7,17]]},"reference":[{"key":"2940_CR1","volume-title":"StatPearls Publishing Copyright \u00a9 2022","author":"M Mueller","year":"2022","unstructured":"Mueller M, Escherichia TCR, Coli, in StatPearls. StatPearls Publishing Copyright \u00a9 2022. Treasure Island (FL): StatPearls Publishing LLC; 2022."},{"key":"2940_CR2","doi-asserted-by":"publisher","first-page":"e00862","DOI":"10.1128\/AAC.00862-20","volume":"64","author":"AE Stapleton","year":"2020","unstructured":"Stapleton AE, Wagenlehner FME, Mulgirigama A, Twynholm M. Escherichia coli resistance to fluoroquinolones in community-acquired uncomplicated urinary tract infection in women: a Systematic Review. Antimicrob Agents Chemother. 2020;64:e00862-e920.","journal-title":"Antimicrob Agents Chemother"},{"issue":"10","key":"2940_CR3","first-page":"1719","volume":"10","author":"TDM Pham","year":"2019","unstructured":"Pham TDM, Ziora ZM. Blaskovich MAT. Quinolone antibiotics Medchemcomm. 2019;10(10):1719\u201339.","journal-title":"Quinolone antibiotics Medchemcomm"},{"issue":"2","key":"2940_CR4","doi-asserted-by":"publisher","first-page":"200","DOI":"10.3934\/microbiol.2021013","volume":"7","author":"ED Ayobola","year":"2021","unstructured":"Ayobola ED, Oscar WO, Ejovwokoghene EF. Plasmid-mediated quinolone resistance genes transfer among enteric bacteria isolated from human and animal sources. AIMS Microbiol. 2021;7(2):200\u201315.","journal-title":"AIMS Microbiol"},{"key":"2940_CR5","doi-asserted-by":"crossref","unstructured":"Mares M, Lim SHE, Lai K-S, Cristina R-T, editors. Antimicrobial resistance: A one health perspective. London, England: IntechOpen; 2021.","DOI":"10.5772\/intechopen.87316"},{"issue":"1","key":"2940_CR6","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1042\/EBC20160063","volume":"61","author":"M Arzanlou","year":"2017","unstructured":"Arzanlou M, Chai WC, Venter H. Intrinsic, adaptive and acquired antimicrobial resistance in Gram-negative bacteria. Essays Biochem. 2017;61(1):49\u201359.","journal-title":"Essays Biochem"},{"issue":"1","key":"2940_CR7","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1186\/s13756-019-0489-3","volume":"8","author":"J Li","year":"2019","unstructured":"Li J, Zhang H, Ning J, Sajid A, Cheng G, Yuan Z, et al. The nature and epidemiology of OqxAB, a multidrug efflux pump. Antimicrob Resist Infect Control. 2019;8(1):44.","journal-title":"Antimicrob Resist Infect Control"},{"issue":"5","key":"2940_CR8","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1099\/jmm.0.000475","volume":"66","author":"S Correia","year":"2017","unstructured":"Correia S, Poeta P, H\u00e9braud M, Luis Capelo J, Igrejas G. Mechanisms of quinolone action and resistance: where do we stand? J Med Microbiol. 2017;66(5):551\u20139.","journal-title":"J Med Microbiol"},{"issue":"4","key":"2940_CR9","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1128\/CMR.00016-09","volume":"22","author":"J Strahilevitz","year":"2009","unstructured":"Strahilevitz J, Jacoby GA, Hooper DC, Robicsek A. Plasmid-mediated quinolone resistance: a multifaceted threat. Clin Microbiol Rev. 2009;22(4):664\u201389.","journal-title":"Clin Microbiol Rev"},{"key":"2940_CR10","doi-asserted-by":"publisher","first-page":"24","DOI":"10.3389\/fmicb.2012.00024","volume":"3","author":"L Poirel","year":"2012","unstructured":"Poirel L, Cattoir V, Nordmann P. Plasmid-mediated quinolone resistance; interactions between human, animal, and environmental ecologies. Front Microbiol. 2012;3:24.","journal-title":"Front Microbiol"},{"issue":"10","key":"2940_CR11","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.3390\/antibiotics10101193","volume":"10","author":"C Kenyon","year":"2021","unstructured":"Kenyon C. Positive association between the use of quinolones in food animals and the prevalence of fluoroquinolone resistance in E. coli and K. pneumoniae, A. baumannii and P. aeruginosa: A global ecological analysis. Antibiotics. 2021;10(10):1193.","journal-title":"Antibiotics"},{"key":"2940_CR12","doi-asserted-by":"publisher","first-page":"976273","DOI":"10.1155\/2012\/976273","volume":"2012","author":"A Dalhoff","year":"2012","unstructured":"Dalhoff A. Global fluoroquinolone resistance epidemiology and implications for clinical use. Interdiscip Perspect Infect Dis. 2012;2012:976273.","journal-title":"Interdiscip Perspect Infect Dis"},{"issue":"4","key":"2940_CR13","doi-asserted-by":"publisher","first-page":"413","DOI":"10.3390\/antibiotics10040413","volume":"10","author":"L Belotindos","year":"2021","unstructured":"Belotindos L, Villanueva M, Miguel J Jr, Bwalya P, Harada T, Kawahara R, et al. Prevalence and characterization of quinolone-resistance determinants in Escherichia coli isolated from food-producing animals and animal-derived food in the Philippines. Antibiotics. 2021;10(4):413.","journal-title":"Antibiotics"},{"key":"2940_CR14","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1186\/s12879-015-1282-4","volume":"15","author":"O Fasugba","year":"2015","unstructured":"Fasugba O, Gardner A, Mitchell BG, Mnatzaganian G. Ciprofloxacin resistance in community- and hospital-acquired Escherichia coli urinary tract infections: a systematic review and meta-analysis of observational studies. BMC Infect Dis. 2015;15:545.","journal-title":"BMC Infect Dis"},{"key":"2940_CR15","doi-asserted-by":"publisher","first-page":"790184","DOI":"10.3389\/fcimb.2022.790184","volume":"12","author":"M Halaji","year":"2022","unstructured":"Halaji M, Fayyazi A, Rajabnia M, Zare D, Pournajaf A, Ranjbar R. Phylogenetic group distribution of uropathogenic Escherichia coli and related antimicrobial resistance pattern: A meta-analysis and systematic review. Front Cell Infect Microbiol. 2022;12:790184.","journal-title":"Front Cell Infect Microbiol"},{"key":"2940_CR16","doi-asserted-by":"publisher","first-page":"169","DOI":"10.4103\/ijpvm.IJPVM_419_17","volume":"10","author":"SAR Mortazavi-Tabatabaei","year":"2019","unstructured":"Mortazavi-Tabatabaei SAR, Ghaderkhani J, Nazari A, Sayehmiri K, Sayehmiri F, Pakzad I. Pattern of antibacterial resistance in urinary tract infections: A systematic review and meta-analysis. Int J Prev Med. 2019;10:169.","journal-title":"Int J Prev Med"},{"issue":"3","key":"2940_CR17","doi-asserted-by":"publisher","first-page":"162","DOI":"10.4103\/jrpp.JRPP_19_42","volume":"8","author":"H Abbasian","year":"2019","unstructured":"Abbasian H, Hajimolaali M, Yektadoost A, Zartab S. Antibiotic utilization in Iran 2000\u20132016: Pattern analysis and benchmarking with organization for economic co-operation and development countries. J Res Pharm Pract. 2019;8(3):162\u20137.","journal-title":"J Res Pharm Pract"},{"issue":"3","key":"2940_CR18","first-page":"177","volume":"12","author":"G Hassanshahi","year":"2020","unstructured":"Hassanshahi G, Darehkordi A, Sheikh Fathollahi M, Khanamani Falahati-Pour S, Rezazadeh Zarandi E, Assar SH. Resistance pattern of Escherichia coli to levofloxacin in Iran: a narrative review. Iran J Microbiol. 2020;12(3):177\u201384.","journal-title":"Iran J Microbiol"},{"issue":"11","key":"2940_CR19","doi-asserted-by":"publisher","first-page":"2736","DOI":"10.1128\/AAC.43.11.2736","volume":"43","author":"J Garau","year":"1999","unstructured":"Garau J, Xercavins M, Rodr\u00edguez-Carballeira M, Ram\u00f3n G\u00f3mez-Vera J, Coll I, Vidal D, et al. Emergence and dissemination of quinolone-resistant Escherichia coli in the community. Antimicrob Agents Chemother. 1999;43(11):2736\u201341.","journal-title":"Antimicrob Agents Chemother"},{"issue":"4","key":"2940_CR20","doi-asserted-by":"publisher","first-page":"546","DOI":"10.3201\/eid1104.040699","volume":"11","author":"J Oteo","year":"2005","unstructured":"Oteo J, L\u00e1zaro E, Baquero F, Campos J. Antimicrobial-resistant invasive Escherichia coli. Spain Emerg Infect Dis. 2005;11(4):546\u201353.","journal-title":"Spain Emerg Infect Dis"},{"issue":"1","key":"2940_CR21","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1186\/s12866-020-02051-8","volume":"20","author":"F Mahmoodi","year":"2020","unstructured":"Mahmoodi F, Rezatofighi SE, Akhoond MR. Antimicrobial resistance and metallo-beta-lactamase producing among commensal Escherichia coli isolates from healthy children of Khuzestan and Fars provinces; Iran. BMC Microbiol. 2020;20(1):366.","journal-title":"BMC Microbiol"},{"issue":"1","key":"2940_CR22","doi-asserted-by":"publisher","first-page":"3372","DOI":"10.1038\/s41598-021-82693-4","volume":"1","author":"E Nji","year":"2021","unstructured":"Nji E, Kazibwe J, Hambridge T, Joko CA, Larbi AA, Damptey LAO, et al. High prevalence of antibiotic resistance in commensal Escherichia coli from healthy human sources in community settings. Sci Rep. 2021;1(1):3372.","journal-title":"Sci Rep"},{"issue":"1","key":"2940_CR23","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/s13756-021-00887-x","volume":"10","author":"E Nabovati","year":"2021","unstructured":"Nabovati E, TaherZadeh Z, Eslami S, Abu-Hanna A, Abbasi R. Antibiotic prescribing in inpatient and outpatient settings in Iran: a systematic review and meta-analysis study. Antimicrob Resist Infect Control. 2021;10(1):15.","journal-title":"Antimicrob Resist Infect Control"},{"issue":"6","key":"2940_CR24","doi-asserted-by":"publisher","first-page":"e0127752","DOI":"10.1371\/journal.pone.0127752","volume":"10","author":"H Blaak","year":"2015","unstructured":"Blaak H, Lynch G, Italiaander R, Hamidjaja RA, Schets FM, de Roda Husman AM. Multidrug-resistant and extended spectrum beta-lactamase-producing Escherichia coli in Dutch surface water and wastewater. PLoS ONE. 2015;10(6):e0127752.","journal-title":"PLoS ONE"},{"issue":"4","key":"2940_CR25","first-page":"24","volume":"40","author":"R Dehghanzadeh Reihani","year":"2018","unstructured":"Dehghanzadeh Reihani R, Roshani M, Farshchian M. Determination of antibiotic resistance spectrum in Enterobacteriaceae and Staphylococcus bacteria Isolated from hospital wastewaters in Tabriz, 2015. Med J Tabriz Uni Med Sciences Health Services. 2018;40(4):24\u201330.","journal-title":"Med J Tabriz Uni Med Sciences Health Services"},{"issue":"1","key":"2940_CR26","first-page":"105","volume":"4","author":"M Hadi","year":"2011","unstructured":"Hadi M, Shokoohi R, Ebrahimzadeh Namvar A, Karimi M, Solaimany AM. Antibiotic resistance of isolated bacteria from urban and hospital wastewaters in Hamadan city. Iran J Health Environ. 2011;4(1):105\u201314.","journal-title":"Iran J Health Environ"},{"issue":"7","key":"2940_CR27","doi-asserted-by":"publisher","first-page":"3317","DOI":"10.1007\/s00253-013-5402-z","volume":"98","author":"L Cai","year":"2014","unstructured":"Cai L, Ju F, Zhang T. Tracking human sewage microbiome in a municipal wastewater treatment plant. Appl Microbiol Biotechnol. 2014;98(7):3317\u201326.","journal-title":"Appl Microbiol Biotechnol"},{"issue":"9","key":"2940_CR28","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1089\/mdr.2021.0029","volume":"28","author":"N Habibzadeh","year":"2022","unstructured":"Habibzadeh N, Peeri Doghaheh H, Manouchehri Far M, Alimohammadi Asl H, Iranpour S, Arzanlou M. Fecal carriage of extended-spectrum \u03b2-lactamases and pAmpC producing Enterobacterales in an Iranian community: Prevalence, risk factors, molecular epidemiology, and antibiotic resistance. Microb Drug Resist. 2022;28(9):921\u201334.","journal-title":"Microb Drug Resist"},{"key":"2940_CR29","doi-asserted-by":"publisher","first-page":"2512","DOI":"10.3389\/fmicb.2017.02512","volume":"8","author":"NC Stoppe","year":"2017","unstructured":"Stoppe NC, Silva JS, Carlos C, Saraiva AM, Ottoboni LMM, et al. Worldwide phylogenetic group patterns of Escherichia coli from commensal human and wastewater treatment plant isolates. Front Microbiol. 2017;8:2512.","journal-title":"Front Microbiol"},{"issue":"1","key":"2940_CR30","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1186\/2052-336X-12-42","volume":"12","author":"F Aalipour","year":"2014","unstructured":"Aalipour F, Mirlohi M, Jalali M. Determination of antibiotic consumption index for animal originated foods produced in animal husbandry in Iran, 2010. J Environ Health Sci Eng. 2014;12(1):42.","journal-title":"J Environ Health Sci Eng"},{"issue":"151","key":"2940_CR31","first-page":"41","volume":"27","author":"A Akya","year":"2017","unstructured":"Akya A, Chegenelorestani R, Elahi A, Hamzavi Y. Frequency of plasmid-mediated quinolone resistance genes in extended-spectum \u03b2-lactamase-producing Escherichia coli. J Mazandaran Univ Med Sci. 2017;27(151):41\u201351.","journal-title":"J Mazandaran Univ Med Sci"},{"issue":"10","key":"2940_CR32","doi-asserted-by":"publisher","first-page":"868","DOI":"10.1111\/j.1469-0691.2004.00983.x","volume":"10","author":"JP Butzler","year":"2004","unstructured":"Butzler JP. Campylobacter, from obscurity to celebrity. Clin Microbiol Infect. 2004;10(10):868\u201376.","journal-title":"Clin Microbiol Infect"},{"key":"2940_CR33","unstructured":"Naraghi B, Afsharnia M, Mardaneh J, Kianmehr M, Biglari H, Bazeli J, et al. Pathogenesis traits and antimicrobial resistance pattern in Escherichia coli isolates recovered from sewage. Crescent J Med Biol Sci. 2020; 7(4)."},{"issue":"4","key":"2940_CR34","doi-asserted-by":"publisher","first-page":"322","DOI":"10.4274\/jpr.galenos.2019.16362","volume":"6","author":"K Ghadiri","year":"2019","unstructured":"Ghadiri K, Akya A, Elahi A, Jafari S, Chegenelorestani R. Evaluation of resistance to ciprofloxacin and identification of mutations in topoisomerase genes in Escherichia coli and Klebsiella pneumonia isolated from pediatric urinary tract infections. J Pediatr Res. 2019;6(4):322\u20138.","journal-title":"J Pediatr Res"},{"issue":"1","key":"2940_CR35","first-page":"1","volume":"7","author":"NT Abou El-Khier","year":"2020","unstructured":"Abou El-Khier NT, El Sayed ZM. Molecular detection and frequency of fluoroquinolone-resistant Escherichia coli by multiplex allele specific polymerase chain reaction (MAS-PCR). Egypt J Basic Appl Sci. 2020;7(1):1\u20137.","journal-title":"Egypt J Basic Appl Sci"},{"issue":"1","key":"2940_CR36","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1089\/mdr.2017.0351","volume":"25","author":"K Jazeela","year":"2019","unstructured":"Jazeela K, Chakraborty G, Seetharam Shetty SH, Rohit A, Vijaya Kumar D. Comparison of mismatch amplification mutation assay PCR and PCR-restriction fragment length polymorphism for detection of major mutations in gyrA and parC of Escherichia coli associated with fluoroquinolone resistance. Microb Drug Resist. 2019;25(1):23\u201331.","journal-title":"Microb Drug Resist"},{"issue":"Pt 11","key":"2940_CR37","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.1099\/jmm.0.043307-0","volume":"61","author":"B-T Liu","year":"2012","unstructured":"Liu B-T, Liao X-P, Yang S-S, Wang X-M, Li L-L, Sun J, et al. Detection of mutations in the gyrA and parC genes in Escherichia coli isolates carrying plasmid-mediated quinolone resistance genes from diseased food-producing animals. J Med Microbiol. 2012;61(Pt 11):1591\u20139.","journal-title":"J Med Microbiol"},{"key":"2940_CR38","first-page":"2147","volume":"7","author":"M R\u00f6derova","year":"2016","unstructured":"R\u00f6derova M, Halova D, Papousek I, Dolejska M, Masarikova M, Hanulik V, et al. Characteristics of quinolone resistance in Escherichia coli isolates from humans, animals, and the environment in the Czech Republic. Front Microbiol. 2016;7:2147.","journal-title":"Front Microbiol"},{"key":"2940_CR39","doi-asserted-by":"publisher","first-page":"422","DOI":"10.15324\/kjcls.2018.50.4.422","volume":"50","author":"J Sung","year":"2018","unstructured":"Sung J. Analysis of quinolone resistance determinants in Escherichia coli isolated from clinical specimens and livestock feces. Korean J Clin Lab Sci. 2018;50:422\u201330.","journal-title":"Korean J Clin Lab Sci"},{"key":"2940_CR40","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/j.jgar.2018.04.017","volume":"13","author":"M Mirzaii","year":"2018","unstructured":"Mirzaii M, Jamshidi S, Zamanzadeh M, Marashifard M, Malek Hosseini SAA, Haeili M, et al. Determination of gyrA and parC mutations and prevalence of plasmid-mediated quinolone resistance genes in Escherichia coli and Klebsiella pneumoniae isolated from patients with urinary tract infection in Iran. J Glob Antimicrob Resist. 2018;13:197\u2013200.","journal-title":"J Glob Antimicrob Resist"},{"issue":"5","key":"2940_CR41","first-page":"e122468","volume":"15","author":"A Hajihasani","year":"2022","unstructured":"Hajihasani A, Ebrahimi-Rad M, Rasoulinasab M, Mehdi Aslani M, Shahcheraghi F. The molecular characterization and risk factors of ST131 and non-ST131 Escherichia coli in healthy fecal carriers in Tehran. Iran Jundishapur J Microbiol. 2022;15(5):e122468.","journal-title":"Iran Jundishapur J Microbiol"},{"key":"2940_CR42","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.jgar.2018.11.003","volume":"17","author":"R Azargun","year":"2019","unstructured":"Azargun R, Soroush Barhaghi MH, Samadi Kafil H, Ahangar Oskouee M, Sadeghi V, Memar MY, et al. Frequency of DNA gyrase and topoisomerase IV mutations and plasmid-mediated quinolone resistance genes among Escherichia coli and Klebsiella pneumoniae isolated from urinary tract infections in Azerbaijan. Iran J Glob Antimicrob Resist. 2019;17:39\u201343.","journal-title":"Iran J Glob Antimicrob Resist"},{"issue":"7","key":"2940_CR43","doi-asserted-by":"publisher","first-page":"728","DOI":"10.3855\/jidc.6727","volume":"10","author":"L Anssour","year":"2016","unstructured":"Anssour L, Messai Y, Estepa V, Torres C, Bakour R. Characteristics of ciprofloxacin-resistant Enterobacteriaceae isolates recovered from wastewater of an Algerian hospital. J Infect Dev Ctries. 2016;10(7):728\u201334.","journal-title":"J Infect Dev Ctries"},{"issue":"1","key":"2940_CR44","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.ijantimicag.2009.08.003","volume":"35","author":"DC Moon","year":"2010","unstructured":"Moon DC, Seol SY, Gurung M, Jin JS, Choi CH, Kim J, et al. Emergence of a new mutation and its accumulation in the topoisomerase IV gene confers high levels of resistance to fluoroquinolones in Escherichia coli isolates. Int J Antimicrob Agents. 2010;35(1):76\u20139.","journal-title":"Int J Antimicrob Agents"},{"issue":"8","key":"2940_CR45","doi-asserted-by":"publisher","first-page":"2740","DOI":"10.1128\/JCM.01093-07","volume":"45","author":"A Sorlozano","year":"2007","unstructured":"Sorlozano A, Gutierrez J, Jimenez A, de Dios LJ, Mart\u00ednez JL. Contribution of a new mutation in parE to quinolone resistance in extended-spectrum-beta-lactamase-producing Escherichia coli isolates. J Clin Microbiol. 2007;45(8):2740\u20132.","journal-title":"J Clin Microbiol"},{"issue":"7","key":"2940_CR46","doi-asserted-by":"publisher","first-page":"6244","DOI":"10.3168\/jds.2017-14156","volume":"101","author":"F Yang","year":"2018","unstructured":"Yang F, Zhang SH, Shang X, Wang L, Li H, Wang X. Characteristics of quinolone-resistant Escherichia coli isolated from bovine mastitis in China. J Dairy Sci. 2018;101(7):6244\u201352.","journal-title":"J Dairy Sci"},{"issue":"4","key":"2940_CR47","doi-asserted-by":"publisher","first-page":"e95864","DOI":"10.1371\/journal.pone.0095864","volume":"9","author":"K Zurfluh","year":"2014","unstructured":"Zurfluh K, Abgottspon H, H\u00e4chler H, N\u00fcesch-Inderbinen M, Stephan R. Quinolone resistance mechanisms among extended-spectrum beta-lactamase (ESBL) producing Escherichia coli isolated from rivers and lakes in Switzerland. PLoS ONE. 2014;9(4):e95864.","journal-title":"PLoS ONE"},{"issue":"3","key":"2940_CR48","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1007\/s10096-016-2847-x","volume":"36","author":"B Yanat","year":"2017","unstructured":"Yanat B, Rodr\u00edguez-Mart\u00ednez JM, Touati A. Plasmid-mediated quinolone resistance in Enterobacteriaceae: a systematic review with a focus on Mediterranean countries. Eur J Clin Microbiol Infect Dis. 2017;36(3):421\u201335.","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"2","key":"2940_CR49","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/j.diagmicrobio.2014.03.011","volume":"79","author":"F Sana","year":"2014","unstructured":"Sana F, Mabrouka S, Claudine Q, Faouzi SA, Boubaker Ilhem BB, V\u00e9ronique D. Prevalence and characterization of uropathogenic Escherichia coli harboring plasmid-mediated quinolone resistance in a Tunisian university hospital. Diagn Microbiol Infect Dis. 2014;79(2):247\u201351.","journal-title":"Diagn Microbiol Infect Dis"},{"key":"2940_CR50","doi-asserted-by":"crossref","unstructured":"Jacoby GA, Strahilevitz J, Hooper DC.\u00a0Plasmid-mediated quinolone resistance. Microbiol Spectr. 2014; 2(5).","DOI":"10.1128\/microbiolspec.PLAS-0006-2013"},{"issue":"1","key":"2940_CR51","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.jiph.2017.03.010","volume":"11","author":"MH Al-Agamy","year":"2018","unstructured":"Al-Agamy MH, Aljallal A, Radwan HH, Hibl AM. Characterization of carbapenemases, ESBLs, and plasmid-mediated quinolone determinants in carbapenem-insensitive Escherichia coli and Klebsiella pneumoniae in Riyadh hospitals. J Infect Public Health. 2018;11(1):64\u20138.","journal-title":"J Infect Public Health"},{"key":"2940_CR52","first-page":"953","volume":"5","author":"A Moumouni","year":"2017","unstructured":"Moumouni A, Diagbouga S, Nademb\u00e8ga C, Dabire AM, Salah F, Obiri-Yeboah D, et al. Quinolone resistance (qnr) genes in fecal carriage of extended spectrum beta-lactamases producing Enterobacteria isolated from children in Niger. Curr Res Microbiol Biotechnol. 2017;5:953\u20137.","journal-title":"Curr Res Microbiol Biotechnol"},{"issue":"5","key":"2940_CR53","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1016\/j.phrp.2016.08.003","volume":"7","author":"M Rezazadeh","year":"2016","unstructured":"Rezazadeh M, Baghchesaraei H, Peymani A. Plasmid-mediated quinolone-resistance (qnr) genes in clinical isolates of Escherichia coli collected from several hospitals of Qazvin and Zanjan provinces. Iran Osong Public Health Res Perspect. 2016;7(5):307\u201312.","journal-title":"Iran Osong Public Health Res Perspect"},{"issue":"10","key":"2940_CR54","doi-asserted-by":"publisher","first-page":"4219","DOI":"10.1128\/AAC.00139-10","volume":"54","author":"J Zhao","year":"2010","unstructured":"Zhao J, Chen Z, Chen S, Deng Y, Liu Y, Tian W, et al. Prevalence and dissemination of oqxAB in Escherichia coli isolates from animals, farmworkers, and the environment. Antimicrob Agents Chemother. 2010;54(10):4219\u201324.","journal-title":"Antimicrob Agents Chemother"},{"key":"2940_CR55","doi-asserted-by":"publisher","first-page":"119","DOI":"10.15344\/2456-4028\/2017\/119","volume":"2","author":"M Khalil","year":"2017","unstructured":"Khalil M, Elsherif R, Ghaith D, Ismail DK, Mohamed S, Jastaniah S, et al. Quinolone resistance detection by PCR-RFLP and Multiplex-PCspectrum extended-spectrum \u03b2- lactamase producing Enterobacteriaceae. Int J Clin Med Microbiol. 2017;2:119.","journal-title":"Int J Clin Med Microbiol"},{"issue":"1","key":"2940_CR56","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1111\/1758-2229.12019","volume":"5","author":"O Clermont","year":"2013","unstructured":"Clermont O, Christenson JK, Denamur E, Gordon DM. The Clermont Escherichia coli phylo-typing method revisited: improvement of specificity and detection of new phylo-groups. Environ Microbiol Rep. 2013;5(1):58\u201365.","journal-title":"Environ Microbiol Rep"},{"issue":"Pt 12","key":"2940_CR57","doi-asserted-by":"publisher","first-page":"3575","DOI":"10.1099\/mic.0.26486-0","volume":"149","author":"DM Gordon","year":"2003","unstructured":"Gordon DM, Cowling A. The distribution and genetic structure of Escherichia coli in Australian vertebrates: host and geographic effects. Microbiology. 2003;149(Pt 12):3575\u201386.","journal-title":"Microbiology"},{"key":"2940_CR58","doi-asserted-by":"publisher","DOI":"10.1016\/j.nmni.2019.100517","volume":"29","author":"F Nojoomi","year":"2019","unstructured":"Nojoomi F, Ghasemian A. The relation of phylogroups, serogroups, virulence factors and resistance pattern of Escherichia coli isolated from children with septicemia. New Microbes New Infect. 2019;29: 100517.","journal-title":"New Microbes New Infect"},{"key":"2940_CR59","unstructured":"EPA Wastewater sampling. Number: SESDPROC-306-R3. (February 28, 2013)"},{"key":"2940_CR60","volume-title":"Textbook of diagnostic microbiology","author":"CR Mahon","year":"2018","unstructured":"Mahon CR, Lehman DC. Textbook of diagnostic microbiology. 6th ed. Philadelphia, PA: Saunders; 2018.","edition":"6"},{"key":"2940_CR61","doi-asserted-by":"publisher","DOI":"10.1201\/9781420014495","volume-title":"Antimicrobial susceptibility testing protocols","author":"R Schwalbe","year":"2007","unstructured":"Schwalbe R, Steele-Moore L, Goodwin AC. Antimicrobial susceptibility testing protocols. London, England: CRC Press; 2007."},{"key":"2940_CR62","unstructured":"Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. In: CLSI (32Ed.), 2022. CLSI Standard M07, 11th ed. Wayne, PA, Clinical and Laboratory Standards Institute."},{"key":"2940_CR63","doi-asserted-by":"publisher","first-page":"101211","DOI":"10.1016\/j.genrep.2021.101211","volume":"24","author":"F Khademi","year":"2021","unstructured":"Khademi F, Maarofi K, Arzanlou M, Peeri-Dogaheh H, Sahebkar A. Which missense mutations associated with DNA gyrase and topoisomerase IV are involved in Pseudomonas aeruginosa clinical isolates resistance to ciprofloxacin in Ardabil? Gene Rep. 2021;24:101211.","journal-title":"Gene Rep"},{"issue":"2","key":"2940_CR64","doi-asserted-by":"publisher","first-page":"186","DOI":"10.5578\/mb.20935","volume":"50","author":"CK Buruk","year":"2016","unstructured":"Buruk CK, Ocak HO, Bayramo\u011flu G. Ayd\u0131n F.Investigation of plasmid-mediated quinolone resistance genes in quinolone-resistant Escherichia coli and Klebsiella spp. isolates from bloodstream infections. Mikrobiyol Bul. 2016;50(2):186\u201395.","journal-title":"Mikrobiyol Bul"},{"issue":"9","key":"2940_CR65","doi-asserted-by":"publisher","first-page":"1316","DOI":"10.1089\/mdr.2017.0354","volume":"24","author":"SM Hamed","year":"2018","unstructured":"Hamed SM, Aboshanab KMA, El-Mahallawy HA, Helmy MM, Ashour MS, Elkhatib WF. Plasmid-mediated quinolone resistance in gram-negative pathogens isolated from cancer patients in Egypt. Microb Drug Resist. 2018;24(9):1316\u201325.","journal-title":"Microb Drug Resist"},{"issue":"5\u20136","key":"2940_CR66","first-page":"247","volume":"85","author":"GF Helaly","year":"2010","unstructured":"Helaly GF, Abou Shleib H, Fanaki NH, Kader OA, Ali GH. Potential co-prevalence of plasmid-mediated quinolone resistance determinant qepA and 16S rRNA methylase rmtB among E.coli clinical isolates from Alexandria- Egypt. J Egypt Public Health Assoc. 2010;85(5\u20136):247\u201372.","journal-title":"J Egypt Public Health Assoc"}],"container-title":["BMC Microbiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12866-023-02940-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12866-023-02940-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12866-023-02940-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,21]],"date-time":"2024-05-21T05:10:34Z","timestamp":1716268234000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmicrobiol.biomedcentral.com\/articles\/10.1186\/s12866-023-02940-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,17]]},"references-count":66,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["2940"],"URL":"https:\/\/doi.org\/10.1186\/s12866-023-02940-8","relation":{},"ISSN":["1471-2180"],"issn-type":[{"value":"1471-2180","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,7,17]]},"assertion":[{"value":"15 March 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 July 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 July 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All experimental protocols in this study were approved by the regional ethics committee of the Ardabil University of Medical Sciences under the reference \u201cIR.ARUMS.REC.1399.553\u201d. All methods were carried out in accordance with relevant guidelines and regulations. Clinical isolates were obtained from the bacterial collection of the hospital for research purposes and no patient samples or data were used in this study. In order to collect samples from healthy children, informed consent was obtained from their parents or legal guardians. To collect the wastewater samples, permissions were obtained from Ardabil Water and Wastewater Company for municipal wastewater treatment plant and Ardabil provincial Veterinary Organization office for poultry and livestock slaughterhouse wastewater treatment plants.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not Applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"191"}}